Jenna Kleman

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Circulating Tumor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)